PTC Works To Resolve English Funding Concerns Over Duchenne Drug Before Access Deal Ends

Translarna could delay the time at which the ability to walk is lost by patients with DMD • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Europe